Small cell lung cancer
no clinical trials 48 substances studiedView
- Substances:Al8326Alisertib Sodium+46 more
Rare diseases archive
Explore rare diseases studied in clinical trials – page 24
619 rare diseases in the catalogue0 linked trials
Top 10 most studied rare diseases
Rare diseases with the highest number of active trials right now.
No. 1 most studied
Acoustic neuroma
0Active trials · 1% of the top 10
- recruiting now
- 0
- countries
- 0
- open to children
- 0
- substance tested
- 1
Shares are of these ten diseases' active trials together.
All rare diseases
Browse every rare disease currently studied across European trials.
A–Z
619 rare diseases
Small cell lung cancer extensive stage
no clinical trials 34 substances studiedView
- Substances:AprepitantAtezolizumab+32 more
Small cell lung cancer metastatic
no clinical trials 7 substances studiedView
- Substances:BNT327Carboplatin+5 more
Small intestine adenocarcinoma
no clinical trials 2 substances studiedView
- Substances:Calcium LevofolinateLevoleucovorin
Small intestine carcinoma
no clinical trials 4 substances studiedView
- Substances:Anhydrous DocetaxelBalstilimab+2 more
Small intestine carcinoma metastatic
no clinical trialsSmall intestine leiomyosarcoma
no clinical trials 2 substances studiedView
- Substances:TrabectedinTtf-Ngr
Small intestine neuroendocrine tumour
no clinical trials 3 substances studiedView
- Substances:DotatateCopper (64Cu) Chloride+1 more
Soft tissue sarcoma
no clinical trials 24 substances studiedView
- Substances:ADCE-D01Aldesleukin+22 more
Solitary fibrous tumour
no clinical trials 1 substance studiedView
- Substances:Eribulin
Spina bifida
no clinical trials 1 substance studiedView
- Substances:OXYBUTYNIN HYDROCHLORIDE
Spinal muscular atrophy
no clinical trials 8 substances studiedView
- Substances:ApitegromabBIIB115+6 more
Splenic marginal zone lymphoma
no clinical trials 6 substances studiedView
- Substances:EpcoritamabObinutuzumab+4 more
Squamous cell carcinoma of the hypopharynx
no clinical trials 3 substances studiedView
- Substances:AfatinibLenvatinib+1 more
Squamous cell carcinoma of the oral cavity
no clinical trials 12 substances studiedView
- Substances:AfatinibCarboplatin+10 more
Squamous cell carcinoma of the vagina
no clinical trials 2 substances studiedView
- Substances:DurvalumabTremelimumab
Squamous cell carcinoma of the vulva
no clinical trials 3 substances studiedView
- Substances:DurvalumabTremelimumab+1 more
Stargardt's disease
no clinical trials 4 substances studiedView
Stevens-Johnson syndrome
no clinical trialsStill's disease
no clinical trials 4 substances studiedView
- Substances:AnakinraApremilast+2 more
Strongyloidiasis
no clinical trials 1 substance studiedView
- Substances:Ivermectin
Subacute cutaneous lupus erythematosus
no clinical trials 2 substances studiedView
- Substances:DeucravacitinibLitifilimab
Supranuclear palsy
no clinical trials 1 substance studiedView
- Substances:Psilocybine
Synovial sarcoma
no clinical trials 16 substances studiedView
- Substances:DabrafenibDecitabine+14 more
About rare diseases in clinical trials
A disease is called rare in the EU when it affects fewer than 5 in 10 000 people. Individually uncommon, together they affect millions – and most still have no approved treatment.
Because the number of patients is small, trials in rare diseases often recruit across several countries at once. That is why a trial listed here may be worth looking at even when it runs nowhere near you.